ANNOUNCEMENT NO. 321
19 October 2026
ChemoMetec A/S will publish its financial results for the first quarter of the 2026/27 financial year on Thursday, November 5, 2026.
In this connection, ChemoMetec A/S will host a conference call on Friday, November 6, 2026, at 3:00 PM CET, during which CEO Martin Helbo Behrens and CFO Phillip Massie Price will present the financial results for the first quarter and answer questions.
The conference call will be held in English.
The webcast can be accessed via this link.
Additional Information
Martin Helbo Behrens, CEO
Tel.: (+45) 81 10 06 80
Phillip Massie Price, CFO
Tel.: (+45) 81 10 06 80
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies.
ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com.
Attachment
